22nd Century Group Announces $21M Debt Financing to Expand Working Capital for Growth Initiatives
22nd Century (NASDAQ:XXII) Group, Inc. (Nasdaq: XXII), the worlds leading biotechnology company dedicated to improving health with reduced nicotine tobacco and advanced plant technologies in both hem…